Skip to main content

Verisk Analytics, Inc. (VRSK) Stock Analysis

Recovery setup

SellDEATH CROSS (EXEMPT)Moderate Confidence

Industrials · Consulting Services

Sell if holding. At $183.25, A.R:R 0.8:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 9.3%; Concentration risk — Customer: U.S. P&C primary insurers (70.0%).

Verisk provides data analytics and technology to the global insurance industry, with all top-100 U.S. P&C insurers as clients in 2025. Revenue is subscription-based, primarily from U.S. property and casualty insurers who accounted for approximately 70% of total revenues in 2025.

$183.25+9.3% A.UpsideScore 5.4/10#5 of 7 Consulting Services
Stop $170.68Target $199.38(analyst − 10%)A.R:R 0.8:1
Analyst target$221.53+20.9%17 analysts
$199.38our TP
$183.25price
$221.53mean
$275

Sell if holding. At $183.25, A.R:R 0.8:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 9.3%; Concentration risk — Customer: U.S. P&C primary insurers (70.0%). Chart setup: Death cross but MACD improving, RSI 70. Score 5.4/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, positive momentum, no SEC red flags, earnings proximity no date, semi cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

Thesis

Rewards
Strong earnings beat streak (4/4)
High-quality business
Risks
Concentration risk — Customer: U.S. P&C primary insurers (70.0%)
Thin upside margin: 9.3%
Weak growth

Key Metrics

P/E (TTM)28.6
P/E (Fwd)21.9
Mkt Cap$24.7B
EV/EBITDA19.1
Profit Mgn29.3%
ROE
Rev Growth3.9%
Beta
Dividend1.06%
Rating analysts26

Quality Signals

Piotroski F8/9

Options Flow

P/C0.90neutral
IV44%normal
Max Pain$260+41.9% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHCustomerU.S. P&C primary insurers70%
    10-K Item 1A: 'approximately 70% of our revenue was derived from solutions provided to U.S. P&C primary insurers'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
3.0
Revenue Growth
3.5

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
1.4
Bollinger
3.0
Support Resistance
3.1
Gap
6.0
GatesA.R:R 0.8 < 1.5@spotMomentum 5.4<5.5 (soft — BUY_NOW allowed but watch)Death cross exempted (quality + momentum high enough)Momentum 5.4>=4.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
70 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $161.70Resistance $191.51

Price Targets

$171
$199
A.Upside+8.8%
A.R:R0.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Reward/Risk 0.8:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-04-29 (nulld)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is VRSK stock a buy right now?

Sell if holding. At $183.25, A.R:R 0.8:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 9.3%; Concentration risk — Customer: U.S. P&C primary insurers (70.0%). Chart setup: Death cross but MACD improving, RSI 70. Prior stop was $170.68. Score 5.4/10, moderate confidence.

What is the VRSK stock price target?

Take-profit target: $199.38 (+9.3% upside). Prior stop was $170.68. Stop-loss: $170.68.

What are the risks of investing in VRSK?

Concentration risk — Customer: U.S. P&C primary insurers (70.0%); Thin upside margin: 9.3%; Weak growth.

Is VRSK overvalued or undervalued?

Verisk Analytics, Inc. trades at a P/E of 28.6 (forward 21.9). TrendMatrix value score: 4.6/10. Verdict: Sell.

What do analysts say about VRSK?

26 analysts cover VRSK with a consensus score of 3.7/5. Average price target: $222.

What does Verisk Analytics, Inc. do?Verisk provides data analytics and technology to the global insurance industry, with all top-100 U.S. P&C insurers as...

Verisk provides data analytics and technology to the global insurance industry, with all top-100 U.S. P&C insurers as clients in 2025. Revenue is subscription-based, primarily from U.S. property and casualty insurers who accounted for approximately 70% of total revenues in 2025.

Related stocks: FCN (FTI Consulting, Inc.) · EFX (Equifax, Inc.) · BAH (Booz Allen Hamilton Holding Cor) · MLI (Mueller Industries, Inc.) · CDLR (Cadeler A/S)